Invention Grant
- Patent Title: Glucagon analogues
-
Application No.: US15983822Application Date: 2018-05-18
-
Publication No.: US10253081B2Publication Date: 2019-04-09
- Inventor: Jakob Lind Tolborg , Keld Fosgerau , Pia Nørregaard , Rasmus Just , Ditte Riber , Dieter Wolfgang Hamprecht , Robert Augustin , Leo Thomas , Wolfgang Rist
- Applicant: Zealand Pharma A/S
- Applicant Address: DK Glostrup
- Assignee: Zealand Pharma A/S
- Current Assignee: Zealand Pharma A/S
- Current Assignee Address: DK Glostrup
- Agency: Clark & Elbing LLP
- Priority: EP12184744 20120917
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/605 ; A61K38/26 ; A61K45/06
Abstract:
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
Public/Granted literature
- US20190055296A1 GLUCAGON ANALOGUES Public/Granted day:2019-02-21
Information query
IPC分类:
